| Citation: | Mao Wenjun, Chen Jingyu. Clinical application of ex vivo lung perfusion technique[J]. ORGAN TRANSPLANTATION, 2018, 9(5): 334-338. doi: 10.3969/j.issn.1674-7445.2018.05.002
|
| [1] |
CHAMBERS DC, YUSEN RD, CHERIKH WS, et al.The registry of the International Society for Heart and Lung Transplantation:thirty-fourth adult lung and heart-lung transplantation report-2017;focus theme:allograft ischemic time[J].J Heart Lung Transplant, 2017, 36(10):1047-1059.DOI: 10.1016/j.healun.2017.07.016.
|
| [2] |
VAN RAEMDONCK D, NEYRINCK A, VERLEDEN GM, et al.Lung donor selection and management[J].Proc Am Thorac Soc, 2009, 6(1):28-38.DOI: 10.1513/pats.200808-098GO.
|
| [3] |
BHARAT A, KUO E, STEWARD N, et al.Immunological link between primary graft dysfunction and chronic lung allograft rejection[J].Ann Thorac Surg, 2008, 86(1):189-195.DOI: 10.1016/j.athoracsur.2008.03.073.
|
| [4] |
LEE JC, CHRISTIE JD, KESHAVJEE S.Primary graft dysfunction:definition, risk factors, short- and long-term outcomes[J].Semin Respir Crit Care Med, 2010, 31(2):161-171.DOI: 10.1055/s-0030-1249111.
|
| [5] |
SHAVER CM, DIAMOND JM, SCHREPFER S, et al.Optimization of oxygenation during ex vivo lung perfusion-best basic science article in 2017[J].J Heart Lung Transplant, 2018, 37(6):800-802.DOI: 10.1016/j.healun.2018.02.010.
|
| [6] |
YEUNG JC, ZAMEL R, KLEMENT W, et al.Towards donor lung recovery-gene expression changes during ex vivo lung perfusion of human lungs[J].Am J Transplant, 2018, 18(6):1518-1526.DOI: 10.1111/ajt.14700.
|
| [7] |
ABOELNAZAR NS, HIMMAT S, HATAMI S, et al.Negative pressure ventilation decreases inflammation and lung edema during normothermic ex-vivo lung perfusion[J].J Heart Lung Transplant, 2018, 37(4):520-530.DOI: 10.1016/j.healun.2017.09.007.
|
| [8] |
ORENS JB, BOEHLER A, DE PERROT M, et al.A review of lung transplant donor acceptability criteria[J].J Heart Lung Transplant, 2003, 22(11):1183-1200. doi: 10.1016/S1053-2498(03)00096-2
|
| [9] |
毛文君, 陈静瑜.中国肺移植面临的困难及对策[J/CD].中华胸部外科电子杂志, 2016, 3(1): 1-6.DOI: 10.3877/cma.j.issn.2095-8773.2016.01.001.
MAO WJ, CHEN JY.Difficulties and countermeasures of lung transplantation in China[J/CD].Chin J Thorac Surg (Electr Edit), 2016, 3(1): 1-6.DOI: 10.3877/cma.j.issn.2095-8773.2016.01.001.
|
| [10] |
MACHUCA TN, CYPEL M.Ex vivo lung perfusion[J].J Thorac Dis, 2014, 6(8):1054-1062.DOI: 10.3978/j.issn.2072-1439.2014.07.12.
|
| [11] |
D' CUNHA HC, ROJAS M.Ex vivo lung perfusion:past, present, and future[J].ASAIO J, 2018, 64(2):135-139.DOI: 10.1097/MAT.0000000000000650.
|
| [12] |
SLAMA A, SCHILLAB L, BARTA M, et al.Standard donor lung procurement with normothermic ex vivo lung perfusion:a prospective randomized clinical trial[J].J Heart Lung Transplant, 2017, 36(7):744-753.DOI: 10.1016/j.healun.2017.02.011.
|
| [13] |
YEUNG JC, CYPEL M, KESHAVJEE S.Ex-vivo lung perfusion:the model for the organ reconditioning hub[J].Curr Opin Organ Transplant, 2017, 22(3):287-289.DOI: 10.1097/MOT.0000000000000404.
|
| [14] |
REEB J, CYPEL M.Ex vivo lung perfusion[J].Clin Transplant, 2016, 30(3):183-194.DOI: 10.1111/ctr.12680.
|
| [15] |
SANCHEZ PG, BITTLE GJ, WILLIAMS K, et al.Ex vivo lung evaluation of prearrest heparinization in donation after cardiac death[J].Ann Surg, 2013, 257(3):534-541.DOI: 10.1097/SLA.0b013e318273bef1.
|
| [16] |
SANCHEZ PG, DAVIS RD, D' OVIDIO F, et al.The novel lung trial one-year outcomes[J].Int Soc Heart Lung Transplant, 2014, 33(4):S71–S72. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=Doaj000004046996
|
| [17] |
TIKKANEN JM, CYPEL M, MACHUCA TN, et al.Functional outcomes and quality of life after normothermic ex vivo lung perfusion lung transplantation[J].J Heart Lung Transplant, 2015, 34(4):547-556.DOI: 10.1016/j.healun.2014.09.044.
|
Figures(2) / Tables(1)
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad:
